Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
- 31 August 2011
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 122 (2), 307-312
- https://doi.org/10.1016/j.ygyno.2011.04.050
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervixCellular & Molecular Immunology, 2010
- CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancerNature Reviews Clinical Oncology, 2010
- Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancerBMC Cancer, 2009
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJCI Insight, 2007
- Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancerCritical Reviews in Oncology/Hematology, 2006
- Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cellsBlood, 2006
- Carcinoma of the VulvaInternational Journal of Gynecology & Obstetrics, 2006
- Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivoJCI Insight, 2006
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Patterns of recurrence in patients with squamous cell carcinoma of the vulvaCancer, 2000